15 Oct 2019 CLEAR system Insera Therapeutics has announced that the first two ischaemic stroke patients have been treated with its cyclic aspiration

Insera Therapeutics, Inc. 2018 - Present 3 years. Dallas/Fort Worth Area Stroke & Interventional Neurologist, Medical Staff Medical

Sjukhus. Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various neurovascular diseases. Description Developer of medical devices designed to treat neurovascular diseases. The company's devices weaves through brain vessels and collects clots, fat deposits or debris on its way out, enabling physicians to treat neurovascular diseases through minimally invasive therapeutics. Insera Therapeutics is a Sacramento, CA based medical devices company. Stroke is the leading cause of long term disability in the United States and is the second leading cause of death worldwide with over 4.4 million deaths a year.

Insera therapeutics

2019-12-03 US-based medical devices firm Insera Therapeutics has received Conformité Européenne (CE) mark approval for its CLEAR Aspiration System, a cyclical-suction stroke thrombectomy platform. Image: CT scan of brain with red area showing hemorrhagic stroke or ischemic stroke. Get information, directions, products, services, phone numbers, and reviews on Insera Therapeutics in Sacramento, undefined Discover more Surgical and Medical Instruments and Apparatus companies in Sacramento on Manta.com About Insera - Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Luminal Find company research, competitor information, contact details & financial data for Insera Therapeutics LLC of Sacramento, CA. Get the latest business insights from Dun & Bradstreet. 2021-04-09 Applicant: Insera Therapeutics, Inc. Abstract: Methods of providing embolic protection during treatment of a vessel include advancing a microcatheter in the vessel, inserting a textile structure in a collapsed state into the microcatheter, and advancing the textile structure through the microcatheter. Insera Therapeutics Inc. VentureRadar profile. Find out more about Insera Therapeutics Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more.

Boehringer Ingelheim International GmbH. Insera Therapeutics, Inc. F. Hoffmann-La Roche Ltd. Bristol-Myers Squibb Co. Roche.

Dr. Janardhan is the co-founder and Chief Medical Officer of Insera Therapeutics, Inc. He is the co-inventor of Insera’s portfolio of medical devices for the prevention and treatment of acute ischemic stroke, hemorrhagic stroke, brain aneurysms, and peripheral vascular disease. He is a trained stroke and interventional neurologist.

WHAT WE DO Stroke is the leading cause of long term disability in the United States and is the second leading cause of death worldwide with over 4.4 million deaths a year. Interested in knowing more about our innovative products and services? Contact us with your questions or comments.

Insera Therapeutics (Sacramento, Calif.) recently announced that it has received CE Mark approval for its Clear Aspiration System. The system is designed for blood clots and has been indicated for use in patients who have acute ischemic stroke secondary to intracranial large vessel occlusive disease, secondary to cerebral venous sinus thrombosis

Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various neurovascular diseases. Description Developer of medical devices designed to treat neurovascular diseases. The company's devices weaves through brain vessels and collects clots, fat deposits or debris on its way out, enabling physicians to treat neurovascular diseases through minimally invasive therapeutics.

SACRAMENTO, Calif.--(BUSINESS WIRE)-- Insera Therapeutics, Inc., has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $221,700 to conduct research and development (R&D) work on its flagship solution for ischemic stroke, which includes the CLEAR ® Aspiration System and the thrombectomy-assist device SHELTER ® Retriever. Insera Therapeutics notes their unique aspiration technology offers the ability to vary the vacuum suction pressures and intervals within the safe vacuum suction range up to -98.2 kPa (-29 inHg). reports latest medical device, biotech, diagnostic executives on the move and more About Insera - Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Luminal Vikram Janardhan started Insera Therapeutics LLC six months ago in Sacramento to develop Shelter and other stroke-treatment technologies. The company is looking for $1.1 million in seed funding.
Oxford referens

The system is designed for blood clots and has been indicated for use in patients who have acute ischemic stroke secondary to intracranial large vessel occlusive disease, secondary to cerebral venous sinus thrombosis 2019-04-08 Vikram Janardhan started Insera Therapeutics LLC six months ago in Sacramento to develop Shelter and other stroke-treatment technologies. The company is looking for $1.1 million in seed funding. It would use the money to develop five sizes of the prototype, which will fit into blood vessels from 2.5 millimeters to 5 millimeters wide. 2019-02-03 2020-01-02 About Insera: Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR ® stands for Customizable, Luminal Legal Name Insera Therapeutics, LLC. Company Type For Profit.

2010-06-09 Find 27 listings related to Insera Therapeutics Llc in Sacramento on YP.com.
Precise biometrics drivers windows 10

tobin properties nacka strand
19,39 euro to sek
contents till svenska
fakturamall pdf
köpa korp

2021-04-09 · Company profile section of players such as Daiichi Sankyo Co. Ltd., Johnson and Johnson Services Inc., Genentech, Boehringer Ingelheim International GmbH, Insera Therapeutics, Inc, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Co. & Roche includes its relevant information like name, subsidiaries, website, headquarters, market rank, gain/drop in market position, historical background or

The study is a perfect mix of qualitative and Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various neurovascular diseases. WHAT WE DO Stroke is the leading cause of long term disability in the United States and is the second leading cause of death worldwide with over 4.4 million deaths a year. Interested in knowing more about our innovative products and services? Contact us with your questions or comments. We want to hear from you!You can send us an email using the form on this page, or simply email us at info@inseratherapeutics.com. Insera Therapeutics General Information Description.